Eli Lilly and Company (NYSE: LLY) in several transactions, including:
- its acquisition of LimmaTech Biologics, a clinical-stage biotechnology company.
- its $7.8 billion acquisition of Centessa Pharmaceuticals plc (Nasdaq: CNTA).
- its $1.3 billion acquisition of Verve Therapeutics, Inc. (Nasdaq: VERV).
KKR in several transactions, including:
- its $2 billion acquisition of Nothing Bundt Cakes.
- its $2.2 billion sale of Novaria Group to Arcline Investment Management.
Uber Technologies (NYSE: UBER) in its acquisition of SpotHero.
Uplift Investors in its acquisition of IMS Legal Strategies.
Warburg Pincus in its investment in Raptor Technologies.
Altas Partners on the sale of minority stakes in Pye-Barker Fire & Safety to the Abu Dhabi Investment Authority and GIC.
Altas Partners in its investment in Redwood Services.
